Mechanochemical Synthesis and Biological Evaluation of Novel Isoniazid Derivatives with Potent Antitubercular Activity. 2017

Paulo F M Oliveira, and Brigitte Guidetti, and Alain Chamayou, and Christiane André-Barrès, and Jan Madacki, and Jana Korduláková, and Giorgia Mori, and Beatrice Silvia Orena, and Laurent Roberto Chiarelli, and Maria Rosalia Pasca, and Christian Lherbet, and Chantal Carayon, and Stéphane Massou, and Michel Baron, and Michel Baltas
Department of Process Engineering, Université de Toulouse, Mines-Albi, CNRS UMR 5302, Centre RAPSODEE, Campus Jarlard, 81013 Albi, France. paul_marqs@hotmail.com.

A series of isoniazid derivatives bearing a phenolic or heteroaromatic coupled frame were obtained by mechanochemical means. Their pH stability and their structural (conformer/isomer) analysis were checked. The activity of prepared derivatives against Mycobacterium tuberculosis cell growth was evaluated. Some compounds such as phenolic hydrazine 1a and almost all heteroaromatic ones, especially 2, 5 and 7, are more active than isoniazid, and their activity against some M. tuberculosis MDR clinical isolates was determined. Compounds 1a and 7 present a selectivity index >1400 evaluated on MRC5 human fibroblast cells. The mechanism of action of selected hydrazones was demonstrated to block mycolic acid synthesis due to InhA inhibition inside the mycobacterial cell.

UI MeSH Term Description Entries
D007536 Isomerism The phenomenon whereby certain chemical compounds have structures that are different although the compounds possess the same elemental composition. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Isomerisms
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D011789 Quantum Theory The theory that the radiation and absorption of energy take place in definite quantities called quanta (E) which vary in size and are defined by the equation E Quantum Theories,Theories, Quantum,Theory, Quantum
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002855 Chromatography, Thin Layer Chromatography on thin layers of adsorbents rather than in columns. The adsorbent can be alumina, silica gel, silicates, charcoals, or cellulose. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Chromatography, Thin-Layer,Thin Layer Chromatography,Chromatographies, Thin Layer,Chromatographies, Thin-Layer,Thin Layer Chromatographies,Thin-Layer Chromatographies,Thin-Layer Chromatography

Related Publications

Paulo F M Oliveira, and Brigitte Guidetti, and Alain Chamayou, and Christiane André-Barrès, and Jan Madacki, and Jana Korduláková, and Giorgia Mori, and Beatrice Silvia Orena, and Laurent Roberto Chiarelli, and Maria Rosalia Pasca, and Christian Lherbet, and Chantal Carayon, and Stéphane Massou, and Michel Baron, and Michel Baltas
June 2014, European journal of medicinal chemistry,
Paulo F M Oliveira, and Brigitte Guidetti, and Alain Chamayou, and Christiane André-Barrès, and Jan Madacki, and Jana Korduláková, and Giorgia Mori, and Beatrice Silvia Orena, and Laurent Roberto Chiarelli, and Maria Rosalia Pasca, and Christian Lherbet, and Chantal Carayon, and Stéphane Massou, and Michel Baron, and Michel Baltas
October 2020, Bioorganic & medicinal chemistry letters,
Paulo F M Oliveira, and Brigitte Guidetti, and Alain Chamayou, and Christiane André-Barrès, and Jan Madacki, and Jana Korduláková, and Giorgia Mori, and Beatrice Silvia Orena, and Laurent Roberto Chiarelli, and Maria Rosalia Pasca, and Christian Lherbet, and Chantal Carayon, and Stéphane Massou, and Michel Baron, and Michel Baltas
September 2015, Chemical biology & drug design,
Paulo F M Oliveira, and Brigitte Guidetti, and Alain Chamayou, and Christiane André-Barrès, and Jan Madacki, and Jana Korduláková, and Giorgia Mori, and Beatrice Silvia Orena, and Laurent Roberto Chiarelli, and Maria Rosalia Pasca, and Christian Lherbet, and Chantal Carayon, and Stéphane Massou, and Michel Baron, and Michel Baltas
November 2012, Archiv der Pharmazie,
Paulo F M Oliveira, and Brigitte Guidetti, and Alain Chamayou, and Christiane André-Barrès, and Jan Madacki, and Jana Korduláková, and Giorgia Mori, and Beatrice Silvia Orena, and Laurent Roberto Chiarelli, and Maria Rosalia Pasca, and Christian Lherbet, and Chantal Carayon, and Stéphane Massou, and Michel Baron, and Michel Baltas
February 2019, European journal of medicinal chemistry,
Paulo F M Oliveira, and Brigitte Guidetti, and Alain Chamayou, and Christiane André-Barrès, and Jan Madacki, and Jana Korduláková, and Giorgia Mori, and Beatrice Silvia Orena, and Laurent Roberto Chiarelli, and Maria Rosalia Pasca, and Christian Lherbet, and Chantal Carayon, and Stéphane Massou, and Michel Baron, and Michel Baltas
February 2019, Molecules (Basel, Switzerland),
Paulo F M Oliveira, and Brigitte Guidetti, and Alain Chamayou, and Christiane André-Barrès, and Jan Madacki, and Jana Korduláková, and Giorgia Mori, and Beatrice Silvia Orena, and Laurent Roberto Chiarelli, and Maria Rosalia Pasca, and Christian Lherbet, and Chantal Carayon, and Stéphane Massou, and Michel Baron, and Michel Baltas
February 2012, Chemical biology & drug design,
Paulo F M Oliveira, and Brigitte Guidetti, and Alain Chamayou, and Christiane André-Barrès, and Jan Madacki, and Jana Korduláková, and Giorgia Mori, and Beatrice Silvia Orena, and Laurent Roberto Chiarelli, and Maria Rosalia Pasca, and Christian Lherbet, and Chantal Carayon, and Stéphane Massou, and Michel Baron, and Michel Baltas
June 2007, Natural product research,
Paulo F M Oliveira, and Brigitte Guidetti, and Alain Chamayou, and Christiane André-Barrès, and Jan Madacki, and Jana Korduláková, and Giorgia Mori, and Beatrice Silvia Orena, and Laurent Roberto Chiarelli, and Maria Rosalia Pasca, and Christian Lherbet, and Chantal Carayon, and Stéphane Massou, and Michel Baron, and Michel Baltas
September 2017, European journal of medicinal chemistry,
Paulo F M Oliveira, and Brigitte Guidetti, and Alain Chamayou, and Christiane André-Barrès, and Jan Madacki, and Jana Korduláková, and Giorgia Mori, and Beatrice Silvia Orena, and Laurent Roberto Chiarelli, and Maria Rosalia Pasca, and Christian Lherbet, and Chantal Carayon, and Stéphane Massou, and Michel Baron, and Michel Baltas
November 2011, European journal of medicinal chemistry,
Copied contents to your clipboard!